Kristiina Vuori
Director/Board Member bei BIONANO GENOMICS, INC.
Vermögen: 71 419 $ am 30.04.2024
Aktive Positionen von Kristiina Vuori
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIONANO GENOMICS, INC. | Director/Board Member | 06.06.2019 | - |
Independent Dir/Board Member | 06.06.2019 | - | |
FORIAN INC. | Director/Board Member | 02.03.2021 | - |
Independent Dir/Board Member | 02.03.2021 | - | |
INHIBRX, INC. | Director/Board Member | 28.10.2021 | - |
Independent Dir/Board Member | 28.10.2021 | - | |
California Breast Cancer Research Program | Director/Board Member | - | - |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
Director/Board Member | 01.01.2005 | - | |
Chief Executive Officer | 01.01.2013 | 01.01.2014 | |
Chief Tech/Sci/R&D Officer | 01.01.2008 | 01.01.2010 | |
Sanford Consortium For Regenerative Medicine
Sanford Consortium For Regenerative Medicine Miscellaneous Commercial ServicesCommercial Services The Sanford Consortium for Regenerative Medicine is a collaborative research organization based in San Diego, CA. The non-profit company's mission is to advance stem cell research through multi-disciplinary interactions. The consortium includes scientists from the La Jolla Institute for Allergy & Immunology, the Salk Institute for Biological Studies, the Sanford Burnham Prebys Medical Discovery Institute, Scripps Research, and the University of California. The CEO of the company is Edward W. Holmes. | Director/Board Member | - | - |
Sanford Stem Cell Clinical Center | Director/Board Member | - | - |
Florida Inventors Hall of Fame | Director/Board Member | - | - |
Karriereverlauf von Kristiina Vuori
Ehemalige bekannte Positionen von Kristiina Vuori
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SIO GENE THERAPIES INC. | Director/Board Member | 06.10.2020 | 05.04.2023 |
Independent Dir/Board Member | 06.10.2020 | 05.04.2023 | |
░░░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░ ░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Kristiina Vuori
University of Oulu | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 15 |
Finnland | 2 |
Operativ
Director/Board Member | 15 |
Independent Dir/Board Member | 5 |
Chief Executive Officer | 3 |
Sektoral
Health Technology | 4 |
Technology Services | 4 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BIONANO GENOMICS, INC. | Health Technology |
INHIBRX, INC. | Health Technology |
FORIAN INC. | Technology Services |
Private Unternehmen | 11 |
---|---|
WebMD Health Corp.
WebMD Health Corp. Internet Software/ServicesTechnology Services WebMD Health Corp. engages in the provision of health information services. It serves physicians, health care professionals, employers, and health plans through public and private online portals, mobile platforms, and health-focused publications. The company is headquartered in New York, NY. | Technology Services |
WebMD, Inc.
WebMD, Inc. Internet Software/ServicesTechnology Services WebMD, Inc. provides Internet-based services and information for physicians and health care information services for consumers | Technology Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
Sanford Burnham Prebys Medical Discovery Institute
Sanford Burnham Prebys Medical Discovery Institute Medical/Nursing ServicesHealth Services Sanford Burnham Prebys Medical Discovery Institute conducts and translates biological research programs. The firm offers tumor initiation and maintenance, cancer metabolism and signaling network, tumor microenvironment and cancer immunology, degenerative disease, development/aging/regeneration, immunity and pathogenesis, human genetic, cardiovascular metabolism, integrative metabolism, metabolism genomic control, bioinformatics and structural biology programs. The company was founded by William Fishman and Lillian Fishman in 1976 and is headquartered in La Jolla, CA. | Health Services |
California Institute for Regenerative Medicine | Government |
California Breast Cancer Research Program | |
Sanford Consortium For Regenerative Medicine
Sanford Consortium For Regenerative Medicine Miscellaneous Commercial ServicesCommercial Services The Sanford Consortium for Regenerative Medicine is a collaborative research organization based in San Diego, CA. The non-profit company's mission is to advance stem cell research through multi-disciplinary interactions. The consortium includes scientists from the La Jolla Institute for Allergy & Immunology, the Salk Institute for Biological Studies, the Sanford Burnham Prebys Medical Discovery Institute, Scripps Research, and the University of California. The CEO of the company is Edward W. Holmes. | Commercial Services |
Sio Gene Therapies, Inc.
Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
Sanford Stem Cell Clinical Center | |
Florida Inventors Hall of Fame |
- Börse
- Insiders
- Kristiina Vuori
- Erfahrung